Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Oxidoreductase
Reexamination Certificate
2001-09-21
2003-09-02
Achutamurthy, Ponnathapu (Department: 1652)
Chemistry: molecular biology and microbiology
Enzyme , proenzyme; compositions thereof; process for...
Oxidoreductase
C435S252300, C435S440000, C536S023200
Reexamination Certificate
active
06613554
ABSTRACT:
FIELD OF THE INVENTION
The present invention is in the field of enzyme proteins that are related to the steroid oxidoreductase subfamily, recombinant DNA molecules, and protein production. The present invention specifically provides novel peptides and proteins that effect protein phosphorylation and nucleic acid molecules encoding such peptide and protein molecules, all of which are useful in the development of human therapeutics and diagnostic compositions and methods.
BACKGROUND OF THE INVENTION
Many human enzymes serve as targets for the action of pharmaceutically active compounds. Several classes of human enzymes that serve as such targets include helicase, steroid esterase and sulfatase, convertase, synthase, dehydrogenase, monoxygenase, transferase, kinase, glutanase, decarboxylase, isomerase and reductase. It is therefore important in developing new pharmaceutical compounds to identify target enzyme proteins that can be put into high-throughput screening formats. The present invention advances the state of the art by providing novel human drug target enzymes related to the steroid oxidoreductase subfamily.
The present invention has substantial similarity to 3&bgr;-hydroxy-5-C27-steroid oxidoreductase (C
27
3&bgr;-HSD). 3&bgr;-hydroxy-5-C27-steroid oxidoreductase involves in the synthesis of bile acids.
Bile acids are important components of normal physiology with essential functions in the liver and small intestine. Their synthesis in the liver provides a metabolic pathway for the catabolism of cholesterol and their detergent properties promote the solubilization of essential nutrients and vitamins in the small intestine. The synthesis of bile acids was thought to involve as many as three separate pathways. Each pathway differs in the initial steps and in the involvement of distinct sterol 7-hydroxylase enzymes that add an essential hydroxyl group to carbon seven of the sterol ring. After the addition of this group, the next step in each pathway is catalyzed by a 3&bgr;-hydroxy-5-C27-steroid oxidoreductase, which isomerizes the 5 bond to the 4 position and oxidizes the 3&bgr;-hydroxyl group to a 3-oxo moiety on intermediates with 27 carbon atoms.
The 3&bgr;-HSD enzyme family consists of a large number of proteins that are present in both prokaryotes and eukaryotes. They are proposed to play a wide variety of anabolic and catabolic roles in intermediary metabolism, and, consistent with this broad function, they are expressed in abundance in organisms ranging from viruses to humans.
C
27
3&bgr;-HSD enzyme deficiency is marked by accumulation of C
27
sterol intermediates of bile acid synthesis, progressive intrahepatic cholestasis, and no endocrine abnormalities. Inherited conditions that prevent the synthesis of bile acids can cause the accumulation of cholesterol and liver dysfunction (cholestasis), underscoring the essential role of bile acids in metabolism. Progressive neonatal intrahepatic cholestasis is marked by jaundice, fat-soluble vitamin deficiency, and lipid malabsorption and is a rare condition of diverse etiologies. Among the causes of this disorder are inborn errors of metabolism that affect the production and secretion of bile. In the absence of a normal bile flow and bile acid pool size, the end products of heme metabolism are not secreted, and their accumulation causes the characteristic jaundice. Dietary fat-soluble vitamins are not effectively taken up in the intestine, leading to deficiencies in hemostasis, and hydrophobic lipids such as long-chain fatty acids and cholesterol are poorly absorbed causing fatty stools. It has been reported that a deficiency of this enzyme can be treated by oral administration of bile acids. For a review relate to the oxidoreductase, see Schwarz et al., J Clin Invest 2000 November;106(9):1175-84.
Enzyme proteins, particularly members of the steroid oxidoreductase subfamily, are a major target for drug action and development. Accordingly, it is valuable to the field of pharmaceutical development to identify and characterize previously unknown members of this subfamily of enzyme proteins. The present invention advances the state of the art by providing previously unidentified human enzyme proteins, and the polynucleotides encoding them, that have homology to members of the steroid oxidoreductase subfamily. These novel compositions are useful in the diagnosis, prevention and treatment of biological processes associated with human diseases.
SUMMARY OF THE INVENTION
The present invention is based in part on the identification of amino acid sequences of human enzyme peptides and proteins that are related to the steroid oxidoreductase subfamily, as well as allelic variants and other mammalian orthologs thereof. These unique peptide sequences, and nucleic acid sequences that encode these peptides, can be used as models for the development of human therapeutic targets, aid in the identification of therapeutic proteins, and serve as targets for the development of human therapeutic agents that modulate enzyme activity in cells and tissues that express the enzyme. Experimental data as provided in
FIG. 1
indicates expression in humans in the brain, kidney, colon and uterus.
REFERENCES:
patent: WO 00/77023 (2000-09-01), None
patent: WO 01/44448 (2001-06-01), None
patent: WO 00/55174 (2002-08-01), None
International Search Report, Aug. 16, 2002.
Database EMBL Online! Accession No. AC021142: “The sequence ofHomo sapiensclone.”: Jan. 16, 2000.
Database EMBL Online! Accession No. BC004929: “Homo sapiens, 3 beta-hydroxy-delta 5-C27-steroid oxidoreductase, clone MGC: 10497 Image: 362669, mRNA, complete cds.”: Mar. 25, 2001.
Database EMBL Online! Accession No. Q9H2F3: “Q9H2F3.” Mar. 1, 2001.
Beasley Ellen M.
DiFrancesco Valentina
Wei Ming-Hui
Yan Chunhua
Achutamurthy Ponnathapu
Applera Corporation
Genomics Celera
Karjala Justin D.
Pak Yong
LandOfFree
Isolated human enzyme, nucleic acid molecules encoding human... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolated human enzyme, nucleic acid molecules encoding human..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolated human enzyme, nucleic acid molecules encoding human... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3112588